Argatroban as an anticoagulant for both hematologic and chemical tests

Journal of Clinical Laboratory Analysis

Volumn 14, Issue 4, 2000, Pages 136-140

  Kumura, Takeo ^a   Hino, Masayuki ^a   Yamane, Takahisa ^a   Tatsumi, Noriyuki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anticoagulant; Argatroban; Chemical tests; Ethylendiamine tetra acetic acid (EDTA); Hematologic tests

Indexed keywords

ARGATROBAN;

ANTICOAGULATION; ARTICLE; BLOOD CELL COUNT; BLOOD EXAMINATION; BLOOD STORAGE; CHEMICAL STRUCTURE; CLINICAL CHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; ERYTHROCYTE STRUCTURE; EVALUATION; FEMALE; HUMAN; LABORATORY TEST; MALE; NORMAL HUMAN; REPRODUCIBILITY;

ANTICOAGULANTS; BLOOD CELL COUNT; CHELATING AGENTS; CHEMISTRY, CLINICAL; EDETIC ACID; FEMALE; HEMATOLOGY; HUMANS; LEUKOCYTE COUNT; MALE; PIPECOLIC ACIDS; REPRODUCIBILITY OF RESULTS;

EID: 0033912254     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2825(2000)14:4<136::AID-JCLA2>3.0.CO;2-1     Document Type: Article

References (11)

1. Okamoto S, Hijikata A, Ikezawa K. A new series of synthetic thrombin inhibitors (OM-inhibitors) having extremely potent and selective action. Thromb Res Suppl 1972;8:77-82.
2. Okamoto S, Hijikata A, Kikumoto R. A synthetic thrombin inhibitor taking extremely active stereostructures. Thromb Hacmostas 1979; 42:205.
3. Hijikata A, Okamoto S, Mon E, et al. In vivo and in vitro studies of a new series of synthetic thrombin inhibitors. Thromb Res 1967; 8(Suppl):83-89.
4. Hicks JM. Excessive blood drawing for laboratory tests. N Engl J Med 1999;340:1690.
5. Okamoto S, Hijikata A, Kikumot R, et al. Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion. Biochem Biophys Res Commun 1981;101:440-446.
6. Kumada T, Abiko Y. Comparative study on heparin and a synthetic thrombin inhibitor No. 805 (MD-805) in experimental antithrombin deficient animals. Thromb Res 1981;24:285-298.
7. Marcie J, Hursting PD, Kenneth LA, et al. Novastan (brand of argatroban): a small molecule, direct thrombin inhibitor. Semin Thromb Hemost 1997;23:503-516.
8. Nakamura K, Hatano Y, Mori K. Thrombin-induced vasoconstriction in isolated cerebral arteries and the influence of a synthetic thrombin inhibitor. Thromb Res 1985;40:715-720.
9. Matsuo T, Koide M, Kario K. Development of argatroban, a direct thrombin inhibitor, and its clinical application. Semin Thromb Hemost 1997;23:517-522.
10. Tamao Y, Kikumoto R. 1997. Effect of argatroban, a selective thrombin inhibitor, on animal models of cerebral thrombosis. Semin Thromb Hemost 23:523-530.
11. Kobayashi S, Tazaki Y. Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis. Semin Thromb Hemost 1997;23: 531-534.